drugset / Trial / NCT01058902

The Effect Of Aspirin On Survival in Lung Cancer

NCT01058902 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Lung cancer is the most common cancer in the western world. Only 10 to 15 % of patients diagnosed with lung cancer are suitable for potentially curative surgical treatment. Despite surgery, recurrence of lung cancer still occurs. Aspirin potentially may help increase survival by altering the biochemistry of any potential remaining lung cancer cells. Most lung cancer occurs in smokers. Smokers are at increased risk of heart attacks and strokes. Aspirin has beneficial effects on the heart and brain, potentially reducing the incidence of heart attacks and strokes.

Timeline

Start
2010-08
Primary completion
2015-08
Completion
2020-08

Outcome

Outcome not reported

Stopped (Business): “failed to achive funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg —